Balyasny Asset Management
GH icon

Balyasny Asset Management’s Guardant Health GH Stock Holding History

Balyasny Asset Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-505,608
Closed -$51.6M – 3122
2025
Q4 		$51.6M Sell
505,608
-27,769
-5% -$2.48M 0.07% 346
2025
Q3 		$33.3M Sell
533,377
-30,971
-5% -$1.68M 0.04% 507
2025
Q2 		$29.4M Sell
564,348
-274,644
-33% -$12.3M 0.04% 524
2025
Q1 		$35.7M Sell
838,992
-153,546
-15% -$6.62M 0.06% 394
2024
Q4 		$30.3M Sell
992,538
-30,679
-3% -$863K 0.05% 496
2024
Q3 		$23.5M Buy
+1,023,217
New +$29M 0.04% 569
2024
Q2 		– Sell
-100,519
Closed -$2.07M – 2761
2024
Q1 		$2.07M Sell
100,519
-300,379
-75% -$6.44M ﹤0.01% 1534
2023
Q4 		$10.8M Sell
400,898
-394,335
-50% -$10.3M 0.02% 833
2023
Q3 		$23.6M Buy
795,233
+761,873
+2,284% +$26.8M 0.05% 517
2023
Q2 		$1.19M Sell
33,360
-1,531,621
-98% -$44M ﹤0.01% 1554
2023
Q1 		$36.7M Buy
1,564,981
+463,183
+42% +$13.2M 0.09% 311
2022
Q4 		$30M Buy
1,101,798
+799,736
+265% +$36.6M 0.08% 326
2022
Q3 		$16.3M Sell
302,062
-164,698
-35% -$8.46M 0.05% 499
2022
Q2 		$18.8M Sell
466,760
-339,749
-42% -$16.8M 0.06% 440
2022
Q1 		$53.4M Buy
806,509
+330,327
+69% +$22.6M 0.17% 127
2021
Q4 		$47.6M Buy
+476,182
New +$49.3M 0.16% 144
2021
Q3 		– Sell
-270,947
Closed -$33.6M – 2108
2021
Q2 		$33.6M Buy
+270,947
New +$36.4M 0.16% 156
2021
Q1 		– Sell
-190,022
Closed -$24.5M – 1878
2020
Q4 		$24.5M Buy
190,022
+150,734
+384% +$17.3M 0.14% 204
2020
Q3 		$4.39M Buy
39,288
+13,406
+52% +$1.23M 0.03% 650
2020
Q2 		$2.1M Buy
+25,882
New +$2.09M 0.02% 714

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management's GH Position: Q1 2026 in Review

Balyasny Asset Management sold out of Guardant Health (GH) in Q1 2026, closing a stake of 505,608 shares — an estimated $51.6M sold.

Balyasny Asset Management first reported a position in GH in Q2 2020 and held it in 20 quarters. The position peaked at $53.4M in Q1 2022. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Balyasny Asset Management reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 505,608 Guardant Health shares in Q1 2026, an estimated $51.6M.
  • Balyasny Asset Management first reported a position in Guardant Health in Q2 2020 and held it in 20 quarters.
  • Balyasny Asset Management's Guardant Health position peaked at $53.4M in Q1 2022.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.